Research & Development

Improve metabolic syndrome-linked conditions with Tocotrienol

Evnol-logoThe body of science supporting EVNol SupraBio in the management of metabolic syndrome is increasing and deserves attention. ExcelVite reveals some of the new findings on the proven protective effects of this tocotrienol complex.

Higher rates of mucosal healing for ulcerative colitis and Crohn’s Disease patients

Takeda-Crohns-diseaseTakeda Pharmaceutical Company Limited announced new real-world data evaluating the comparative effectiveness of Entyvio (vedolizumab) and tumor necrosis factor-alpha (TNFα)-antagonist therapy in patients with moderately to severely active ulcerative colitis or Crohn's disease.

New research reveals role of tomato and rosemary for eye health

Tomatoes-on-vine-LycoredLycored, an international wellness company at the forefront of ingredient and nutrition supplements, announced the publication of its pre-clinical results in the peer-reviewed scientific journal, Molecular Vision. Within the paper, scientists unearth the powerful biological synergy that exists between the ingredients found in LycoInvision, Lycored’s Nutrient Complex for Vision Health.

TissUse and AstraZeneca to use Microphysical systems in drug development

Lab stock image TissuseTissUse continues their successful collaboration with AstraZeneca to establish relevant Microphysiological System (MPS) models based on TissUse’s Multi-Organ-Chip technology.

DuPont establishes microbiome venture

DuPont Nutrition & Health Microbiome Venture logoDuPont Nutrition & Health announces the launch of a significant new initiative by creating the Microbiome Venture to spearhead developing new microbiome science-based solutions. The Microbiome Venture will play a key role in DuPont’s business growth strategy.

Would you like to receive our FREE e-newsletter?

* indicates required
Close